A prospective study assessing the early adverse reactions following the first, second, and booster dose of COVID-19 vaccines in healthcare workers (HCWs)
Latest Information Update: 03 Aug 2022
At a glance
- Drugs AZD 1222 (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
Most Recent Events
- 03 Aug 2022 New trial record
- 13 Jun 2022 Results presented at the ASM Microbe 2022